iTeos Therapeutics (ITOS)
(Delayed Data from NSDQ)
$16.70 USD
-0.20 (-1.18%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $15.50 -1.20 (-7.19%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Brokerage Reports
iTeos Therapeutics, Inc. [ITOS]
Reports for Purchase
Showing records 1 - 20 ( 120 total )
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology- ESMO 2024 Abstract Titles for Covered Companies
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Eyes on GALAXIES Lung-201 Update in NSCLC; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Multiple Clinical Updates Expected in 2H24; New PT $46; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Year of Clinical Data Updates and Pipeline Development; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for ITOS 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Gearing Up For a Data-Rich 2024; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S